11+ min ago   (115+ words) Access to medicines is under pressure across the EU, as rising prices for new therapies and growing demand test the limits of public budgets. Between 2020 and 2025, Member States implemented wide-ranging reforms to expand coverage, reduce out-of-pocket costs, and sustain innovation....

1+ hour, 29+ min ago   (69+ words) Kalkine Media OncoSil Medical (ASX:OSL) OSL (ASX:OSL) announced a change in substantial holder interests from Regal Partners Funds Management Pty Limited and its associates, revealing their voting power rose from 9.25% to 13.82%. This is based on the total shares…...

3+ hour, 53+ min ago   (942+ words) Last May, US President Donald Trump pushed to align drug pricing with the lowest levels among other developed nations — so-called most-favoured-nation (MFN) pricing. However, the pricing policy might have negative consequences. European patients might have to wait longer for some…...

3+ hour, 48+ min ago   (41+ words) marketscreener.com Otsuka Holdings Co., Ltd. Otsuka Arm's Lung Cancer Drug Plus Chemotherapy Trial Shows Six-Month Median PFS Benefit Published on 09/14/2026 at 01:08 am EDT...

4+ hour, 42+ min ago   (316+ words) Across OECD countries, healthcare spending has long grown faster than GDP, while health-adjusted life expectancy has stagnated or declined and up to 20% of spending remains directed to low-value care. Outcome-based care measures success by patient outcomes relative to resources used,…...

5+ hour, 43+ min ago   (131+ words) PharmaDispatch Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug....

5+ hour, 56+ min ago   (737+ words) Federal Government plans to stop funding its Prostate Cancer Specialist Nursing Program could cost lives, particularly in rural and regional areas, says Shepparton’s Biggest Ever Blokes Lunch Committee. The government announced on August 31 its intention to end funding for the…...

1+ hour, 53+ min ago   (367+ words) Entropy Neurodynamics reports durable 12-week BED response from TRP-8803, with 50% binge-free and 73% weekly episodes below baseline after two doses. Entropy Neurodynamics (ASX: ENP) has released positive results from a 12-week follow-up on Cohort 1 of the Phase 2 trial of TRP-8803 IV-infused…...

6+ hour, 10+ min ago   (69+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Jiangsu Hengrui Pharmaceuticals Co.,Ltd Hengrui Pharmaceuticals' Lung Cancer…...

2+ hour, 42+ min ago   (318+ words) BioSpace Aptar Pharma Expands Preservative Free Technology Production in Latin America Transfer of Aptar Pharma’s Advanced Preservative Free pump technology to Berazategui, Argentina, strengthens local manufacturing capabilities and supports the company’s local-for-local approach in the region. Located south of Buenos…...